Icosapent ethyl (IPE) 4 g and 2 g/day significantly reduced triglyceride (TG) levels by 21.5% (p<0.0001) and 10.1% (p=0.0005), and other lipid levels, in high-risk, statin-treated patients with residual TG elevations.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
